1. Home
  2. TOMZ vs BCDA Comparison

TOMZ vs BCDA Comparison

Compare TOMZ & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.74

Market Cap

12.5M

Sector

Finance

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$1.10

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
BCDA
Founded
1979
N/A
Country
United States
United States
Employees
N/A
21
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
12.9M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
TOMZ
BCDA
Price
$0.74
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
377.5K
53.5K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
13.64
N/A
EPS
N/A
N/A
Revenue
$5,635,927.00
N/A
Revenue This Year
$48.56
N/A
Revenue Next Year
$121.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$1.00
52 Week High
$1.20
$3.10

Technical Indicators

Market Signals
Indicator
TOMZ
BCDA
Relative Strength Index (RSI) 66.92 34.80
Support Level $0.73 $1.00
Resistance Level $0.80 $1.30
Average True Range (ATR) 0.07 0.05
MACD 0.02 -0.01
Stochastic Oscillator 66.63 0.00

Price Performance

Historical Comparison
TOMZ
BCDA

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: